Research
Hormonal
Very-low-carbohydrate ketogenic diets improve glycemic control, insulin sensitivity, and lipid markers in Type 2 Diabetes (T2D) patients, often allowing for the withdrawal of insulin and other medications.
For Type 2 Diabetics, a VLCKD (under 50g carbs) can dramatically improve blood sugar control, insulin sensitivity, and lipid profiles, often allowing for reduced medication needs, sometimes before significant weight loss occurs.
StrongSupportsVERY_HIGH confidence
In studies that have evaluated well-formulated very-low-carbohydrate diets and documented high rates of compliance in individuals with T2D, results have been nothing short of remarkable... significant improvements in both weight loss and metabolic parameters were seen at 12 weeks and continued throughout the 56 weeks as evidenced by improvements in fasting circulating levels of glucose... high-density lipoprotein–cholesterol... and triglycerides.
Why this rating
The paper cites multiple studies with high compliance, long duration (56 weeks), and dramatic improvements in HbA1c, glucose, and insulin sensitivity.
Source
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Antonio Paoli et al. · European Journal of Clinical Nutrition · 2013
narrative_reviewCited 894×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →